Previous 10 | Next 10 |
Virtual meetings and digital presentations are one way for pharmaceutical companies to continue to sell retailers during the coronavirus shelter-at-home edicts. This is the strategy for Bayer (NYSE: BAYRY) , Pfizer (NYSE: PFE) , Merck (NYSE: MRK ), GlaxoSmithKline (NYSE: GSK ) and ...
Four more states issued coronavirus-related stay-at-home orders Wednesday, including Florida, Nevada, Mississippi and Pennsylvania. CBD licensed dispensaries have been ruled essential businesses and will remain open in Florida and Nevada. In the rest of the nation, states and counties have pro...
More states, such as Florida, issued coronavirus related stay-at-home orders yesterday (April 1, 2020). CBD is not a cure for COVID-19, but it offers relief from anxiety and stress by people who fear they, family or friends may contract it. As a result, we have seen CBD products show staying...
Todd Davis, CEO and Chairman of CBD Unlimited, Inc. (OTC PINK: EDXC ), illustrates a case in point why the CBD market is changing quick with the mass market playing an important role. Where his company was selling mom-and-pop retailers last year, he’s placed his CBD product on more t...
Analysts see the active M&A activity in the CBD market as a great strategy of growing market sales and extending market cap. As the market matures and grows, larger firms will benefit from the consolidation. For example, the move by Charlotte’s Web (NASDAQ: CWBHF) , marketer of h...
Todd Davis, CEO and Chairman of CBD Unlimited, Inc. (OTC PINK: EDXC ), in an update interview with NASDAQ MarketSite reporter Jane King discussed the company’s performance in the 2nd Quarter. Conducted at a remote location, the full interview will be available on April 6, 2020. Davis...
CBD licensed dispensaries, filling refills of patients, have been ruled essential businesses that remain open in California, Nevada, Michigan and Illinois. CBD is available to residents of these states during the coronavirus crisis. Online sales of CBD, always a dominant percentage of th...
The CBD industry’s red-hot M&A activity within the past two months has seen several companies acquired, but none is more intriguing than the move by mainstream firm Colgate Palmolive (NYSE: CL) to acquire Hello Products and its line of oral hygiene products — CBD-infused ...
Under Priority Review status, the FDA accepts for review GW Pharmaceuticals' (NASDAQ: GWPH ) supplemental marketing application seeking approval to use Epidiolex (cannabidiol) to treat seizures associated with tuberous sclerosis complex , a rare inherited disorder in which non-cancerous t...
CARLSBAD, Calif., March 31, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with its U.S. subsidiary Greenwich Biosciences, Inc., today announced that the U.S. Fo...
News, Short Squeeze, Breakout and More Instantly...
GW Pharmaceuticals Plc Company Name:
GWPH Stock Symbol:
NASDAQ Market:
GW Pharmaceuticals Plc Website:
The key to investing is “Buy low, sell high”. According to that mantra, periods of weakness are the mother’s milk of future gains. When you see them, you know “this is my chance”. It’s the chance to get involved. This is especially true in industries ...
NetworkNewsWire Editorial Coverage : In May 2013, GW Pharma listed on Nasdaq, selling 3.5 million shares at $8.90 each to investors betting that GW was charting a profitable course as a biotech developing new drugs from cannabis-derived compounds. Legal cannabis was only beginning to gain...
Real Brands Inc (OTCMKTS:RLBD) snuck one under the radar late last week, but investors interested in the CBD and Cannabis space should take note. The company filed its Form 10 with the SEC. In this case, it was a voluntary filing because the company does report having over $10 million o...